We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: PCOS
MedXY News
EnglishTag

PCOS

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

New Consensus on Testosterone Reference Ranges for Females and Children: Outcomes of the 2024 PCOS Challenge–CDC Stakeholder Meeting
Diabetes & EndocrinologyPCOStestosterone

New Consensus on Testosterone Reference Ranges for Females and Children: Outcomes of the 2024 PCOS Challenge–CDC Stakeholder Meeting

By MedXY|Sep 19, 2026

A stakeholder consensus sets a roadmap to develop standardized, age- and sex-specific testosterone reference intervals for women, adolescent girls, and children to improve diagnosis and care for androgen-related disorders.

Unraveling the Role of 11-Oxygenated Androgens in PCOS: Phenotype-Specific Profiles and Treatment Responses
Diabetes & EndocrinologyPCOSmetformin
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story

Unraveling the Role of 11-Oxygenated Androgens in PCOS: Phenotype-Specific Profiles and Treatment Responses

By MedXY|Sep 3, 2026

This article explores how 11-oxygenated androgens differ by PCOS phenotypes and respond to first-line therapies, emphasizing their role in phenotyping and guiding treatment in polycystic ovary syndrome.

Early Life Adversity and Polycystic Ovary Syndrome among North American Pregnancy Planners: A Comprehensive Review
Clinical UpdatesAdverse Childhood Experiencesearly life adversity

Early Life Adversity and Polycystic Ovary Syndrome among North American Pregnancy Planners: A Comprehensive Review

By MedXY|Jul 1, 2026

This review synthesizes current evidence linking adverse childhood experiences with increased risk and features of PCOS, highlighting possible neuroendocrine mechanisms and clinical implications for reproductive health management.

Adolescent MASLD Plus PCOS Signals a Higher-Risk Cardiometabolic Trajectory Into Adulthood
Diabetes & Endocrinologycardiometabolic riskinsulin resistance

Adolescent MASLD Plus PCOS Signals a Higher-Risk Cardiometabolic Trajectory Into Adulthood

By MedXY|May 28, 2026

In the Raine Study, adolescents with both MASLD and PCOS had a substantially worse cardiometabolic profile by age 27 than peers with either condition alone, highlighting a high-risk subgroup that may warrant earlier metabolic surveillance.

Prepregnancy Insulin Resistance and Fertility Outcomes in Women With PCOS
Diabetes & EndocrinologyPCOSfertility

Prepregnancy Insulin Resistance and Fertility Outcomes in Women With PCOS

By MedXY|Aug 18, 2026

Higher insulin resistance before pregnancy was linked to poorer ovulation, lower pregnancy and live-birth rates, and more gestational diabetes in women with PCOS. Improving insulin resistance during treatment was associated with better preg

Microbial and Metabolic Correlates of Endometrial Dysfunction in Polycystic Ovary Syndrome: A Translational Study
newsgut microbiomePCOS

Microbial and Metabolic Correlates of Endometrial Dysfunction in Polycystic Ovary Syndrome: A Translational Study

By MedXY|Aug 18, 2026

This study links PCOS-related miscarriage risk to gut microbiome changes, especially reduced Parabacteroides merdae and higher isoleucine, which may promote endometrial senescence and impair pregnancy outcomes.

One-Hour Plasma Glucose: A Vital Predictor of Cardiometabolic Risk in Women with PCOS
Diabetes & Endocrinologycardiovascular riskGlucose Testing

One-Hour Plasma Glucose: A Vital Predictor of Cardiometabolic Risk in Women with PCOS

By MedXY|Mar 15, 2026

A retrospective study highlights how 1-hour plasma glucose levels can identify early cardiometabolic risks in women with PCOS who appear to have normal blood sugar levels.

Elevated MCP1 and FABP4 in Early PCOS Pregnancy: Metabolic Markers Driven by Adiposity Rather Than Disease Status
Diabetes & EndocrinologyAdiposityPCOS

Elevated MCP1 and FABP4 in Early PCOS Pregnancy: Metabolic Markers Driven by Adiposity Rather Than Disease Status

By MedXY|Mar 10, 2026

A cross-sectional study reveals that while MCP1 and FABP4 are elevated in early pregnancy among women with PCOS, these biomarkers primarily reflect maternal adiposity and do not independently predict adverse outcomes, highlighting the impor

Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications
Clinical UpdateshyperandrogenismPCOS

Undiagnosed Hyperandrogenism in Type 1 Diabetes: Clinical Evidence, Mechanisms, and Screening Implications

By MedXY|Dec 27, 2025

Recent evidence reveals that one in four premenopausal women with Type 1 diabetes (T1D) suffers from undiagnosed androgen excess disorders, primarily the classic PCOS phenotype, necessitating routine screening and a recalibration of reprodu

One in Four Premenopausal Women with Type 1 Diabetes Faces Undiagnosed Androgen Excess Disorders
Diabetes & EndocrinologyhyperandrogenismNội tiết sinh sản

One in Four Premenopausal Women with Type 1 Diabetes Faces Undiagnosed Androgen Excess Disorders

By MedXY|Dec 27, 2025

A cross-sectional study reveals that 26% of women with Type 1 Diabetes suffer from undiagnosed androgen excess, primarily PCOS. The findings emphasize the role of iatrogenic hyperinsulinism and advocate for routine screening, especially for

PCOS as a Biological Model for Reproductive Longevity: Enhanced Ovarian Reserve and ART Success in Aging Asian Women
Diabetes & EndocrinologyDự trữ buồng trứngPCOS

PCOS as a Biological Model for Reproductive Longevity: Enhanced Ovarian Reserve and ART Success in Aging Asian Women

By MedXY|Dec 25, 2025

A retrospective study of 1,249 Asian women reveals that those with PCOS maintain superior ovarian reserve and stable cumulative pregnancy rates via ART even after age 36, suggesting PCOS may serve as a biological model for extended reproduc

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone
Diabetes & Endocrinologyinsulin resistanceliraglutide

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone

By MedXY|Nov 17, 2025

A 2025 meta-analysis of 19 RCTs (n=1657) found liraglutide combined with metformin improved glycaemia, insulin resistance, BMI, sex hormones and lipids versus metformin alone in overweight or obese women with PCOS; evidence certainty was lo

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone
Diabetes & Endocrinologyinsulin resistanceliraglutide

Liraglutide Plus Metformin in Overweight/Obese PCOS: Greater Metabolic and Hormonal Benefits Than Metformin Alone

By MedXY|Nov 17, 2025

A 2025 meta-analysis of 19 RCTs (n=1657) found liraglutide combined with metformin improved glycaemia, insulin resistance, BMI, sex hormones and lipids versus metformin alone in overweight or obese women with PCOS; evidence certainty was lo

Tirzepatide Produces Large Real‑World Weight Loss in Women with PCOS
Diabetes & EndocrinologyobesityPCOS

Tirzepatide Produces Large Real‑World Weight Loss in Women with PCOS

By MedXY|Nov 13, 2025

A large retrospective real‑world cohort (n=4241) of women with PCOS and overweight/obesity treated with tirzepatide experienced mean 18.8% weight loss at 10 months (90% lost ≥10%); digital engagement amplified outcomes. The data are promisi

Enhanced Therapeutic Benefits of Combined Metformin and Curcumin in Women with Polycystic Ovary Syndrome: Results from a Factorial Clinical Trial
Diabetes & Endocrinologycurcuminhormonal therapy

Enhanced Therapeutic Benefits of Combined Metformin and Curcumin in Women with Polycystic Ovary Syndrome: Results from a Factorial Clinical Trial

By MedXY|Oct 8, 2025

A 12-week randomized trial demonstrates that combining metformin and nanocurcumin significantly improves lipid metabolism, glucose regulation, hormonal balance, and body metrics in women with PCOS, surpassing effects seen with either agent

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide
Clinical Updatesmetforminobesity

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide

By MedXY|Oct 7, 2025

Combination therapy with metformin and semaglutide improves weight loss, metabolic parameters, menstrual function, and natural pregnancy rates in overweight/obese women with PCOS compared to metformin alone.

Gut Microbiota and Pregnancy Risks: the Connection in Polycystic Ovary Syndrome
newsgut microbiotahealth

Gut Microbiota and Pregnancy Risks: the Connection in Polycystic Ovary Syndrome

By MedXY|Sep 30, 2025

Scientific findings link imbalances in gut microbiota and metabolic markers to pregnancy complications in women with PCOS.

Exploring Sexual Function in Women with PCOS: Insights from Recent Research
newsPCOSsexual function

Exploring Sexual Function in Women with PCOS: Insights from Recent Research

By MedXY|Sep 30, 2025

A systematic review assesses sexual function in women with PCOS, revealing impaired psychosexual function and calling for more diverse and comprehensive studies.

Navigating the Complex World of PCOS: A Gender-Diverse Perspective
newshealthcarePCOS

Navigating the Complex World of PCOS: A Gender-Diverse Perspective

By MedXY|Sep 30, 2025

Exploring the unique experiences of gender-diverse individuals with PCOS and its impact on gender identity.

Understanding Idiopathic Hirsutism: A Misnomer in Medical Science?
newshyperandrogenismPCOS

Understanding Idiopathic Hirsutism: A Misnomer in Medical Science?

By MedXY|Sep 30, 2025

Idiopathic hirsutism, characterized by excessive hair growth, may not be truly idiopathic. Research suggests underlying androgen mechanisms could redefine its classification.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities